Document Detail


Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
MedLine Citation:
PMID:  14597587     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: beta-Blockers improve survival and reduce hospitalization in chronic heart failure (CHF) by biologically improving left ventricular ejection fraction (LVEF). However, a good predictor of improvement with this therapy has not been identified. This substudy of BEST examined whether myocardial contractile reserve, as determined by dobutamine stress echocardiography, predicts improvement in LVEF. METHODS AND RESULTS: Seventy-nine patients with class III/IV CHF underwent dobutamine stress echocardiography before treatment with bucindolol (n=41) or placebo (n=38). Regional wall motion score index (WMSI) was calculated as the sum of the scores in each segment divided by the total number of segments visualized. WMSI was compared with change in LVEF after 3 months of therapy as determined by gated radionuclide scan. Change in WMSI correlated inversely with change in LVEF after 3 months of bucindolol (r=-0.72, P<0.0001) and was the most significant multivariate predictor of change in LVEF (P=0.0002). Patients with contractile reserve had demographics similar to those of patients without contractile reserve, including RVEF, LVEF, systolic blood pressure, and CHF duration. However, patients without contractile reserve had higher baseline plasma norepinephrine levels (687+/-333 versus 420+/-246 pg/mL, P<0.05) and greater decrease in plasma norepinephrine in response to bucindolol (-249+/-171 versus -35+/-277 pg/mL, P<0.05). CONCLUSIONS: This study suggests a direct relationship between contractile reserve and improvement in LVEF with beta-blocker therapy in patients with advanced CHF. Patients without contractile reserve have higher resting adrenergic drive, as reflected by plasma norepinephrine, and may experience greater sympatholytic effects from bucindolol.
Authors:
Eric J Eichhorn; Paul A Grayburn; Susan A Mayer; Martin St John Sutton; Christopher Appleton; Jonathan Plehn; Jae Oh; Barry Greenberg; Anthony DeMaria; Robert Frantz; Heidi Krause-Steinrauf
Related Documents :
11748107 - Myocardial contractile function and heart rate in mice with myocyte-specific overexpres...
22931737 - Thrombolysis of ischemic stroke from noncompaction in metabolic myopathy.
24939927 - Outcomes with coronary artery bypass graft surgery versus percutaneous coronary interve...
25052317 - Distal single subcortical infarction had a better clinical outcome compared with proxim...
3591617 - Mechanisms of ventricular tachycardia termination and acceleration during transvenous c...
22840527 - Clinical implications of an implantable cardioverter-defibrillator in patients with vas...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.     Date:  2003-11-03
Journal Detail:
Title:  Circulation     Volume:  108     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-11     Completed Date:  2003-12-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2336-41     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Cardiology Division, the University of Texas Southwestern and Dallas VA Medical Centers, Dallas, USA. eeichhorn@csant.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology,  therapeutic use*
Adult
Aged
Aged, 80 and over
Dobutamine / administration & dosage,  adverse effects,  diagnostic use*
Echocardiography, Stress*
Female
Follow-Up Studies
Heart Failure / blood,  drug therapy,  physiopathology*,  radionuclide imaging
Humans
Male
Middle Aged
Myocardial Contraction / drug effects,  physiology*
Norepinephrine / blood
Propanolamines / pharmacology,  therapeutic use*
Prospective Studies
Stroke Volume / drug effects
Ventricular Function, Left / drug effects
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Propanolamines; 34368-04-2/Dobutamine; 51-41-2/Norepinephrine; 70369-47-0/bucindolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and p...
Next Document:  Effect of posture on blood and intraocular pressures in multiple system atrophy, pure autonomic fail...